Mobile App Developed to Improve Self-Management for Adult Growth Hormone Deficiency

Adult Growth Hormone Deficiency (AGHD) is a chronic endocrine disorder characterized by reduced quality of life, impaired physical activity, and sexual dysfunction, often requiring long-term recombinant human growth hormone (r-hGH) therapy. Effective management relies on continuous monitoring of patient well-being and treatment adherence. However, existing clinical monitoring methods often lack the granularity and continuity needed for comprehensive, patient-centric data collection on daily symptoms and treatment impact, creating a significant knowledge gap in personalized AGHD care.

This study successfully focused on the development, implementation, and initial validation of the MAGHD App/MAGHD Framework as a novel self-assessment system for Adult Growth Hormone Deficiency (AGHD) management. The research involved 83 adult patients, establishing a robust framework for continuous data collection on various patient-reported outcomes. While specific quantitative results regarding the app's efficacy, user satisfaction metrics, or direct impact on clinical markers are not detailed in this record, the study confirmed the feasibility of integrating diverse data streams. > The core finding is the successful development and initial validation of a comprehensive mobile self-assessment system, the MAGHD App, designed to provide continuous, patient-centric data for AGHD management by merging daily patient inputs with clinical records. This innovative system aims to offer a more dynamic and personalized approach to monitoring patient health and treatment response compared to traditional, intermittent clinical assessments.